Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients

Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients

Abstract Background Hepatitis E virus (HEV) may be resistant to immunosuppression reduction and ribavirin treatment in kidney transplant recipients because of mutant strains and severe side effects of ribavirin which conduct to dose reduction. Sofosbuvir efficacy is controversial. Peg-interferon 2 a...

Full description

Bibliographic Details
Main Authors: I. Ollivier-Hourmand, L. Lebedel, A. Lecouf, M. Allaire, T. T. N. Nguyen, C. Lier, T. Dao
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Infectious Diseases
Subjects:
Hepatitis E
Kidney transplantation
Interferon
Ribavirin
Rejection
Online Access:http://link.springer.com/article/10.1186/s12879-020-05212-2

Internet

http://link.springer.com/article/10.1186/s12879-020-05212-2

Similar Items